BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30429287)

  • 1. Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.
    Hu C; Li L; Ding P; Li L; Ge X; Zheng L; Wang X; Wang J; Zhang W; Wang N; Gu H; Zhong F; Xu M; Rong R; Zhu T; Hu W
    J Immunol; 2018 Dec; 201(12):3717-3730. PubMed ID: 30429287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis.
    Thorenz A; Derlin K; Schröder C; Dressler L; Vijayan V; Pradhan P; Immenschuh S; Jörns A; Echtermeyer F; Herzog C; Chen R; Rong S; Bräsen JH; van Kooten C; Kirsch T; Klemann C; Meier M; Klos A; Haller H; Hensen B; Gueler F
    Kidney Int; 2018 Oct; 94(4):741-755. PubMed ID: 29935951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
    Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
    J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol can suppress renal ischemia-reperfusion injury through the activation of PI3K/AKT/mTOR signal pathway.
    Wei Q; Zhao J; Zhou X; Yu L; Liu Z; Chang Y
    Gene; 2019 Aug; 708():14-20. PubMed ID: 31082504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
    Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
    J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
    Yamada K; Miwa T; Liu J; Nangaku M; Song WC
    J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
    Park P; Haas M; Cunningham PN; Alexander JJ; Bao L; Guthridge JM; Kraus DM; Holers VM; Quigg RJ
    J Am Soc Nephrol; 2001 Jul; 12(7):1383-1390. PubMed ID: 11423567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury.
    Yang FJ; He YH; Zhou JH
    J Huazhong Univ Sci Technolog Med Sci; 2015 Feb; 35(1):58-63. PubMed ID: 25673194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labile Heme Aggravates Renal Inflammation and Complement Activation After Ischemia Reperfusion Injury.
    Wang L; Vijayan V; Jang MS; Thorenz A; Greite R; Rong S; Chen R; Shushakova N; Tudorache I; Derlin K; Pradhan P; Madyaningrana K; Madrahimov N; Bräsen JH; Lichtinghagen R; van Kooten C; Huber-Lang M; Haller H; Immenschuh S; Gueler F
    Front Immunol; 2019; 10():2975. PubMed ID: 31921212
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
    Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice.
    Shi Y; Yao W; Sun L; Li G; Liu H; Ding P; Hu W; Xu H
    BMC Nephrol; 2019 Nov; 20(1):424. PubMed ID: 31752725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function.
    Castellano G; Intini A; Stasi A; Divella C; Gigante M; Pontrelli P; Franzin R; Accetturo M; Zito A; Fiorentino M; Montinaro V; Lucarelli G; Ditonno P; Battaglia M; Crovace A; Staffieri F; Oortwijn B; van Amersfoort E; Pertosa G; Grandaliano G; Gesualdo L
    Am J Transplant; 2016 Jan; 16(1):325-33. PubMed ID: 26280899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.
    Zhang J; Hu W; Xing W; You T; Xu J; Qin X; Peng Z
    Am J Pathol; 2011 Dec; 179(6):2876-84. PubMed ID: 22019898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Fc-Elabela-21 on renal ischemia/reperfusion injury in mice: Mediation of anti-apoptotic effect via Akt phosphorylation.
    Xu F; Wu M; Lu X; Zhang H; Shi L; Xi Y; Zhou H; Wang J; Miao L; Gong DW; Cui W
    Peptides; 2022 Jan; 147():170682. PubMed ID: 34742787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell Response.
    Casiraghi F; Azzollini N; Todeschini M; Fiori S; Cavinato RA; Cassis P; Solini S; Pezzuto F; Mister M; Thurman JM; Benigni A; Remuzzi G; Noris M
    Am J Transplant; 2017 Sep; 17(9):2312-2325. PubMed ID: 28276660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy.
    Marshall KM; He S; Zhong Z; Atkinson C; Tomlinson S
    J Exp Med; 2014 Aug; 211(9):1793-805. PubMed ID: 25113972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathological role of IL-18Rα in renal ischemia/reperfusion injury.
    Yano T; Nozaki Y; Kinoshita K; Hino S; Hirooka Y; Niki K; Shimazu H; Kishimoto K; Funauch M; Matsumura I
    Lab Invest; 2015 Jan; 95(1):78-91. PubMed ID: 25329004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4.
    Asgari E; Farrar CA; Lynch N; Ali YM; Roscher S; Stover C; Zhou W; Schwaeble WJ; Sacks SH
    FASEB J; 2014 Sep; 28(9):3996-4003. PubMed ID: 24868011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
    Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
    Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade.
    Kusakabe J; Hata K; Tamaki I; Tajima T; Miyauchi H; Wang Y; Nigmet Y; Okamura Y; Kubota T; Tanaka H; Tsuruyama T; Uemoto S
    Transplantation; 2020 Oct; 104(10):2065-2077. PubMed ID: 32384381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.